{"disease":{"id":"hiv-1-infections","name":"hiv 1 infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01078246","title":"Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)","phase":"","overall_status":"COMPLETED","enrollment_count":7124,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01078233","title":"Observational Data Analysis in EuroSIDA (MK-0518-058)","phase":"","overall_status":"COMPLETED","enrollment_count":6617,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06393387","title":"Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Midway Specialty Care Center","has_results":false},{"nct_id":"NCT03087890","title":"Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":537,"lead_sponsor_name":"University of Bergen","has_results":false},{"nct_id":"NCT01968551","title":"Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT01281813","title":"TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Janssen Sciences Ireland UC","has_results":true},{"nct_id":"NCT00799058","title":"A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"International Partnership for Microbicides, Inc.","has_results":true},{"nct_id":"NCT03729778","title":"Impact of HIV-1 and Aging on Mucosal Vaccine Responses","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"VA Eastern Colorado Health Care System","has_results":false},{"nct_id":"NCT01138605","title":"TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Janssen Sciences Ireland UC","has_results":false},{"nct_id":"NCT05330143","title":"Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Ascletis Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT05601128","title":"A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}